Learning Management System

Skip Over Navigation

Course Description



TB-244 A Practical Approach to Using IGRA in Diagnosing TB


Enrollment DeadlineSectionCourse FormatStart/End Dates Details Instructor(s)Speakers
Enroll
Ongoing
Archived Webinar Online Ongoing
Robert Belknap, MD  


Course Description

Interferon Gamma Release Assays (IGRAs) have been recommended for use in the diagnosis of Latent TB Infection. Since these recommendations, much has been learned and published regarding the performance of these tests in different clinical situations. This Grand Rounds program will examine “lessons learned” from a “practical” standpoint and share experiences for enhancing the utilization of these tests. Presentation by Dr. Robert Belknap.

Goals:

  1. Describe and apply current recommendations for the use of Interferon Gamma Release Assays (IGRAs)
  2. Integrate new information concerning the use of IGRAs into varying clinical situations
  3. Disseminate programmatic experiences gained from clinical implementation of IGRA with other providers

Objectives:

  1. List the benefits and limitations of IGRAs in patients with different TB risks
    • Suspected active TB
    • Special populations
    • High vs. low risk for TB infection​
  2.  ​​Describe the operational advantages and disadvantages using IGRA
  3. Explain some of the cost issues associated with expanded use of IGRAs

Slides:https://sntc.medicine.ufl.edu//Content/Webinars/SupportingDocs//Webinar%20IGRAs%208-13-13.v2.pdf

Transcript:  https://sntc.medicine.ufl.edu//Content/Webinars/SupportingDocs//Transcript-Webinar%20IGRAs%208-13-13FINAL.pdf

 

 

 

Keywords:  TB, Tuberculosis, LTBI, latent tuberculosis infection, latent TB infection, MTB, M. TB complex, Mycobacterium tuberculosis, M. tuberculosis, IGRA, Interferon Gamma Release Assay, Quantiferon Gold In Tube, T Spot

Prerequisites

None

Course Competencies

There are no competencies currently assigned to this course